J. Christy Oliger's Insider Trades & SAST Disclosures
J. Christy Oliger's most recent trade in Vera Therapeutics Inc - Ordinary Shares - Class A was a trade of 14,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Christy Oliger.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vera Therapeutics Inc - Or... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Replimune Group Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| LAVA Therapeutics NV | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 33,390 | 33,390 | - | - | Common Shares (Right to Buy) | |
| Vera Therapeutics Inc - Or... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Replimune Group Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| RayzeBio Inc. | J. Christy Oliger | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2024 | 114,579 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 2,137 | 2,137 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 93.61 per share. | 07 Jun 2023 | 1,682 | 5,565 (0%) | 0% | 93.6 | 157,452 | Class A common stock |
| Karyopharm Therapeutics Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Replimune Group Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 25,200 | 25,200 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 5,620 | 5,620 | - | - | Stock Option (right-to-buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 34.76 per share. | 08 Jun 2022 | 3,883 | 3,883 (0%) | 0% | 34.8 | 134,973 | Class A common stock |
| Karyopharm Therapeutics Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
| Replimune Group Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 180 | 180 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 1,250 | 1,250 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 106 | 106 | - | - | Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 32,800 | 32,800 | - | - | Nonstatutory Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges